½ÃÀ庸°í¼­
»óǰÄÚµå
1747477

¼¼°èÀÇ ¹Ì»ý¹° ½Äº° ½ÃÀå : Á¦Ç° ¹× ¼­ºñ½ºº°, ±â¼úº°, ¹æ¹ýº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Microbial Identification Market, By Product & Service, By Technology, By Method, By End User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ¹Ì»ý¹° ½Äº° ½ÃÀåÀº 2025³â¿¡ 45¾ï 5,000¸¸ ´Þ·¯, 2032³â¿¡´Â 100¾ï 1,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 11.9%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 45¾ï 5,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£(2025-2032³â) CAGR 11.90% 2032³â °¡Ä¡ ¿¹Ãø 100¾ï 1,000¸¸ ´Þ·¯

¼¼°è ¹Ì»ý¹° ½Äº° ½ÃÀåÀº ´Ù¾çÇÑ »ê¾÷ ºÐ¾ß¿¡¼­ ¹Ì»ý¹°ÀÇ ½Å¼ÓÇϰí Á¤È®ÇÑ ½Äº°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÃÖ±Ù ¸î ³â µ¿¾È °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀåÀ» ÀÌ·ç¾ú½À´Ï´Ù. ¹Ì»ý¹° ½Äº°Àº ÇコÄɾî, ½ÄÀ½·á, Á¦¾à, ȯ°æ ºÐ¾ß¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ¹Ì»ý¹°ÀÇ Àû½Ã °ËÃâ ¹× Æ¯¼ºÈ­´Â °ø°ø ¾ÈÀü, ǰÁú °ü¸® ¹× ±ÔÁ¦ Áؼö¸¦ º¸ÀåÇϱâ À§ÇØ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â ¹è¾ç ±â¹Ý ±â¼ú ¹× »ýÈ­ÇÐ °Ë»ç¿Í °°Àº ÀüÅëÀûÀÎ ¹æ¹ýºÎÅÍ ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ(PCR), ¿°±â¼­¿­ ºÐ¼®, Áú·® ºÐ¼®°ú °°Àº °í±Þ ºÐÀÚÁø´Ü µµ±¸¿¡ À̸£±â±îÁö ´Ù¾çÇÑ ±â¼úÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. ±â¼úÀÇ ¹ßÀü°ú ¹Ì»ý¹° µ¿Á¤¿¡ ¼Ò¿äµÇ´Â ½Ã°£ ´ÜÃà¿¡ ´ëÇÑ Á߿伺ÀÌ ºÎ°¢µÇ¸é¼­ ÇâÈÄ ¸î ³â µ¿¾È ½ÃÀåÀÌ Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¼¼°è ¹Ì»ý¹° ½Äº° ½ÃÀåÀº Àü¿°º´ À¯Çà, ½Äǰ ¾ÈÀü ¹× ǰÁú¿¡ ´ëÇÑ °ü½É Áõ°¡, ½Å¼ÓÇϰí Á¤È®ÇÑ Áø´Ü µµ±¸¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖÀ¸¸ç, Äڷγª19 ÆÒµ¥¹ÍÀº Àü¿°º´ È®»êÀ» ¾ïÁ¦ÇÏ´Â µ¥ ÀÖ¾î ¹Ì»ý¹° ½Äº° Á߿伺À» ´õ¿í ºÎ°¢½ÃÄÑ ÀÓ»ó ÇöÀå¿¡¼­ ÷´Ü ±â¼úÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÓ»ó ÇöÀå¿¡¼­ ÷´Ü ±â¼úÀÇ Ã¤ÅÃÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Äǰ, ÀǾàǰ, ȯ°æ ½Ã·áÀÇ ¾ÈÀü°ú ǰÁúÀ» º¸ÀåÇϱâ À§ÇØ Á¤ºÎ ¹× ±ÔÁ¦ ±â°ü¿¡¼­ ½ÃÇàÇÏ´Â ¾ö°ÝÇÑ ±ÔÁ¦°¡ ¹Ì»ý¹° ½Äº° ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ÷´Ü ±â¼úÀÇ ³ôÀº ºñ¿ë°ú ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·Àº ½ÃÀå ¼ºÀåÀ» ¾î´À Á¤µµ ¾ïÁ¦ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µµÀü¿¡µµ ºÒ±¸Çϰí, ÀÌ ½ÃÀåÀº ÇöÀå °Ë»ç ÀåºñÀÇ °³¹ß, µ¥ÀÌÅÍ ºÐ¼®À» À§ÇÑ ÀΰøÁö´É°ú ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀÇ ÅëÇÕ, ¹Ì°³Ã´ ÀáÀç·ÂÀ» Áö´Ñ ½ÅÈï ½ÃÀå ÁøÃâ µî ÀÌ ºÐ¾ß¿¡¼­ »ç¾÷À» Àü°³ÇÏ´Â ±â¾÷µé¿¡°Ô Å« ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ¼¼°èÀÇ ¹Ì»ý¹° ½Äº° ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â) µ¿¾È ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¶»çÇÏ¿© Á¤¸®ÇÑ º¸°í¼­ÀÔ´Ï´Ù.
  • ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ Ã¢Ãâ ±âȸ¸¦ ÆÄ¾ÇÇϰí, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °íÂûÀ» Á¦°øÇÕ´Ï´Ù.
  • ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ¹Ì»ý¹° ½Äº° ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯Çü ¾÷±×·¹À̵å, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ÀÌ º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ¹Ì»ý¹° ½Äº° ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • ¿µÇ⠺м®
  • ÁÖ¿ä ¹ßÀü
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç° ¹ß¸Å ¹× ½ÂÀÎ
  • PEST ºÐ¼®
  • PORTER ºÐ¼®
  • ÀμöÇÕº´(M&A) ½Ã³ª¸®¿À
  • ¾÷°è µ¿Çâ

Á¦4Àå ¼¼°èÀÇ ¹Ì»ý¹° ½Äº° ½ÃÀå, Á¦Ç° ¹× ¼­ºñ½ºº°, 2020³â-2032³â

  • ±â±â
  • ¼Ò¸ðǰ
  • ¼ÒÇÁÆ®¿þ¾î ¹× ¼­ºñ½º

Á¦5Àå ¼¼°èÀÇ ¹Ì»ý¹° ½Äº° ½ÃÀå, ±â¼úº°, 2020³â-2032³â

  • PCR
  • ¸¶ÀÌÅ©·Î¾î·¹ÀÌ
  • NGS(Â÷¼¼´ë ½ÃÄö½Ì)
  • MALDI-TOF
  • Áú·® ºÐ¼®
  • »ýÈ­ÇÐ °Ë»ç
  • À¯¼¼Æ÷ ºÐ¼®±â

Á¦6Àå ¼¼°èÀÇ ¹Ì»ý¹° ½Äº° ½ÃÀå, ¹æ¹ýº°, 2020³â-2032³â

  • Phenotypic Methods
  • Genotypic Methods
  • Proteotypic Methods

Á¦7Àå ¼¼°èÀÇ ¹Ì»ý¹° ½Äº° ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020³â-2032³â

  • º´¿ø
  • Áø´Ü½ÇÇè½Ç
  • Á¦¾à ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • Çмú¿¬±¸±â°ü
  • ±âŸ(CRO)

Á¦8Àå ¼¼°èÀÇ ¹Ì»ý¹° ½Äº° ½ÃÀå, Áö¿ªº°, 2020³â-2032³â

  • ºÏ¹Ì
      • ¹Ì±¹
      • ij³ª´Ù
  • ¶óƾ¾Æ¸Þ¸®Ä«
      • ºê¶óÁú
      • ¾Æ¸£ÇîÆ¼³ª
      • ¸ß½ÃÄÚ
      • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
      • µ¶ÀÏ
      • ¿µ±¹
      • ½ºÆäÀÎ
      • ÇÁ¶û½º
      • ÀÌÅ»¸®¾Æ
      • ·¯½Ã¾Æ
      • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
      • Áß±¹
      • Àεµ
      • ÀϺ»
      • È£ÁÖ
      • Çѱ¹
      • ASEAN
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
      • GCC ±¹°¡
      • À̽º¶ó¿¤
      • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
      • ³²¾ÆÇÁ¸®Ä«
      • ºÏ¾ÆÇÁ¸®Ä«
      • Áß¾Ó¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • BioMerieux
  • Thermo Fisher Scientific
  • Bruker Corporation
  • Agilent Technologies
  • Roche Diagnostics
  • Abbott Laboratories
  • Siemens Healthineers
  • QIAGEN
  • Illumina
  • Becton, Dickinson and Company
  • Merck KGaA
  • Hologic, Inc.
  • Luminex Corporation
  • Genomatix Software GmbH
  • Cepheid

Á¦10Àå ¾Ö³Î¸®½ºÆ® Ãßõ »çÇ×

  • ±âȸ
  • ¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
  • Coherent Opportunity Map

Á¦11Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý

  • Âü°í ¹®Çå
  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç¿¡ ´ëÇØ
LSH 25.06.24

Global Microbial Identification Market is estimated to be valued at USD 4.55 Bn in 2025 and is expected to reach USD 10.01 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.9% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 4.55 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 11.90% 2032 Value Projection: USD 10.01 Bn

The global microbial identification market has witnessed significant growth in recent years, driven by the increasing demand for rapid and accurate identification of microorganisms across various industries. Microbial identification plays a crucial role in healthcare, food and beverage, pharmaceutical, and environmental sectors, where the timely detection and characterization of microbes are essential for ensuring public safety, quality control, and regulatory compliance. The market encompasses a wide range of technologies, including traditional methods such as culture-based techniques and biochemical tests, as well as advanced molecular diagnostic tools like polymerase chain reaction (PCR), sequencing, and mass spectrometry. With advancements in technology and the growing emphasis on reducing the turnaround time for microbial identification, the market is poised for substantial growth in the coming years.

Market Dynamics:

The global microbial identification market is driven by several factors, including the increasing prevalence of infectious diseases, the rising concerns over food safety and quality, and the growing demand for rapid and accurate diagnostic tools. The COVID-19 pandemic has further highlighted the importance of microbial identification in controlling the spread of infectious diseases and has accelerated the adoption of advanced technologies in clinical settings. Moreover, the stringent regulations imposed by governments and regulatory bodies to ensure the safety and quality of food, pharmaceuticals, and environmental samples have fueled the demand for microbial identification solutions. However, the high cost of advanced technologies and the lack of skilled professionals may restrain the market growth to some extent. Despite these challenges, the market presents significant opportunities for players operating in this space, such as the development of point-of-care testing devices, the integration of artificial intelligence and machine learning algorithms for data analysis, and the expansion into emerging markets with untapped potential.

Key Features of the Study:

  • This report provides in-depth analysis of the global microbial identification market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global microbial identification market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include BioMerieux, Thermo Fisher Scientific, Bruker Corporation, Agilent Technologies, Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, QIAGEN, Illumina, Becton, Dickinson and Company, Merck KGaA, Hologic, Inc., Luminex Corporation, Genomatix Software GmbH, and Cepheid
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global microbial identification market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global microbial identification market

Market Segmentation

  • Product & Service Insights (Revenue, USD Bn, 2020 - 2032)
    • Instruments
    • Mass Spectrometry Devices
    • Polymerase Chain Reaction (PCR) Systems
    • Microarray Platform
    • Other Specialized Instruments
    • Consumables
    • Reagents and Diagnostic Kits
    • Culture Plates and Growth Media
    • Software and Services
    • Microbial Identification Services
    • Microbial Culture Preservation Services
    • Assay Development and Validation Services
  • Technology Insights (Revenue, USD Bn, 2020 - 2032)
    • PCR
    • Microarrays
    • NGS (Next-Generation Sequencing)
    • MALDI-TOF
    • Mass Spectrometry
    • Biochemical Tests
    • Flow Cytometry
  • Method Insights (Revenue, USD Bn, 2020 - 2032)
    • Phenotypic Methods
    • Genotypic Methods
    • Proteotypic Methods
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospitals
    • Diagnostic Laboratories
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes
    • Others (CROs)
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • BioMerieux
    • Thermo Fisher Scientific
    • Bruker Corporation
    • Agilent Technologies
    • Roche Diagnostics
    • Abbott Laboratories
    • Siemens Healthineers
    • QIAGEN
    • Illumina
    • Becton, Dickinson and Company
    • Merck KGaA
    • Hologic, Inc.
    • Luminex Corporation
    • Genomatix Software GmbH
    • Cepheid

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Microbial Identification Market, By Product & Service
    • Global Microbial Identification Market, By Technology
    • Global Microbial Identification Market, By Method
    • Global Microbial Identification Market, By End User
    • Global Microbial Identification Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Microbial Identification Market, By Product & Service, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Mass Spectrometry Devices
      • Polymerase Chain Reaction (PCR) Systems
      • Microarray Platform
      • Other Specialized Instruments
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Reagents and Diagnostic Kits
      • Culture Plates and Growth Media
  • Software and Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Microbial Identification Services
      • Microbial Culture Preservation Services
      • Assay Development and Validation Services

5. Global Microbial Identification Market, By Technology, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • PCR
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Microarrays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • NGS (Next-Generation Sequencing)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • MALDI-TOF
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Mass Spectrometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Biochemical Tests
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Flow Cytometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Microbial Identification Market, By Method, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Phenotypic Methods
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Genotypic Methods
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Proteotypic Methods
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Microbial Identification Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pharmaceutical and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Microbial Identification Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Method, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Method, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Method, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Method, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Method, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Method, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • BioMerieux
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bruker Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Agilent Technologies
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Roche Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • QIAGEN
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Illumina
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Becton, Dickinson and Company
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hologic, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Luminex Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Genomatix Software GmbH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cepheid
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦